Follow The Filings

ALLE Allegion

Allegion earnings company data as of 4:28 PM ET 10/23

  • 1 of 1 EPS beats

History

1 period, newest first. Each row shows EPS above revenue.

Period Date Metric Estimate Actual Result
FY2026 Q3 22 Oct EPS 2.48 2.60 Beat +4.8%
Rev — — —

Insider trades

Open-market buys and sales by ALLE's executives, directors and 10% owners in the last 12 months, from their Form 4s

All ALLE insider trades
  • $591K bought by 3 insiders
  • $2M sold by 5 insiders outside a trading plan
  • $587K sold by 2 insiders under 10b5-1 plans
  1. Steven Mizell Director
    Buy
    $27K 170 shares at $158.28 +3% to stake
    Traded Aug 28 Filed Aug 31
  2. David S. Ilardi President-Amer & SVP-Allegion
    Sale
    $88K 549 shares at $161.09 3.8% of stake
    Traded Aug 18 Filed Aug 19
  3. Vincent Wenos SVP - Chief Technology Officer
    Sale
    $168K 1,000 shares at $168.25 7.6% of stake
    Traded Aug 6 Filed Aug 7
  4. Timothy P Eckersley President-Intl & SVP-Allegion
    Sale
    $1M 6,417 shares at $157.26 18% of stake
    Traded Jul 27 Filed Jul 29
  5. Michael J. Wagnes CFO
    Planned sale
    $481K 3,184 shares at $150.98 9.2% of stake
    Traded Jul 23 Filed Jul 27
  6. Nickolas A. Musial VP, Controller & CAO
    Planned sale
    $106K 687 shares at $155.00 9.2% of stake
    Traded Jul 23 Filed Jul 27
  7. Robert C. Martens SVP-Chief Innovation & Design
    Sale
    $548K 3,993 shares at $137.15 32% of stake
    Traded May 7 Filed May 11
  8. Sue Main Director
    Buy
    $299K 2,000 shares at $149.61 New stake
    Traded Mar 11 Filed Mar 12
  9. Steven Mizell Director
    Sale
    $227K 1,400 shares at $162.16 22% of stake
    Traded Feb 18–19 Filed Feb 20
  10. Lauren B Peters Director
    Buy
    $265K 1,600 shares at $165.44 +33% to stake
    Traded Nov 25, 2025 Filed Nov 25, 2025

Also filed in the last 12 months, not counted as buying or selling: 48 share withholdings for taxes, 27 stock grants, 4 option exercises, and 2 gifts.

SEC filings

Recent issuer filings from EDGAR, 16 shown.

Filed Form Detail Links
10-Q 10-Q DATED OCTOBER 22, 2026
8-K 2.02,9.01
8-K 5.02,7.01,9.01
SCHEDULE 13G —
SCHEDULE 13G/A —
8-K 2.02,9.01
10-Q 10-Q DATED JULY 23, 2026
8-K 5.07
SCHEDULE 13G/A —
SCHEDULE 13G —
SCHEDULE 13G —
8-K 2.02,9.01
10-Q 10-Q DATED APRIL 28, 2026
DEF 14A
DEFA14A
8-K 8.01

Estimates are consensus figures; SEC filings remain the official record. Not investment advice.